Forte Capital LLC Novo Nordisk A S Transaction History

Forte Capital LLC

$861 Million
Q2 2025

A detailed history of Forte Capital LLC transactions in Novo Nordisk A S stock. As of the latest transaction made, Forte Capital LLC holds 4,982 shares of NVO stock, worth $241,427. This represents 0.04% of its overall portfolio holdings.

Number of Shares

4,982

Previous 8,689 42.66%

Holding current value

$241,427

Previous $603,000 43.12%

% of portfolio

0.04%

Previous 0.08%

11 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2025 Jul 15, 2025	SELL	$58.08 - $81.05 $215,302 - $300,452	-3,707 Reduced 42.66%	4,982 $343,000
Q1 2025 May 02, 2025	SELL	$69.3 - $90.95 $2.33 Million - $3.05 Million	-33,589 Reduced 79.45%	8,689 $603,000
Q4 2024 Feb 03, 2025	SELL	$85.0 - $120.04 $1.93 Million - $2.73 Million	-22,723 Reduced 34.96%	42,278 $3.64 Million
Q3 2024 Oct 31, 2024	BUY	$119.07 - $145.42 $6.43 Million - $7.86 Million	54,028 Added 492.37%	65,001 $7.74 Million
Q2 2024 Aug 13, 2024	BUY	$122.71 - $146.91 $928,055 - $1.11 Million	7,563 Added 221.79%	10,973 $1.57 Million

Q1 2024 May 14, 2024	SELL	$102.11 - $135.92 $102 - $135	-1 Reduced 0.03%	3,410 $437,000
Q4 2023 Feb 06, 2024	BUY	$87.78 - $105.45 $175 - $210	2 Added 0.06%	3,411 $352,000
Q3 2023 Nov 13, 2023	BUY	$90.94 - $199.54 $154,052 - $338,020	1,694 Added 98.78%	3,409 $310,000
Q2 2023 Aug 09, 2023	SELL	$155.98 - $172.65 $11,698 - $12,948	-75 Reduced 4.19%	1,715 $277,000
Q4 2022 Feb 13, 2023	BUY	$102.55 - $135.33 $183,564 - $242,240	1,790 New	1,790 $242,000
Q2 2022 Aug 09, 2022	BUY	$103.24 - $121.81 $202,350 - $238,747	1,960 New	1,960 $218,000

Others Institutions Holding NVO

# of Institutions

1,693

Shares Held

304M

Call Options Held

25.9M

Put Options Held

43.8M

View Full List

About NOVO NORDISK A S

Ticker NVO
Exchange OTC
Sector Healthcare
Industry Biotechnology
Shares Outstandng 2,257,289,984
Market Cap $109B
Description
Novo Nordisk A/S, a healthcare company, engages in the research, development, manufacture, and marketing of pharmaceutical products worldwide. It operates in two segments, Diabetes and Obesity care, and Biopharm. The Diabetes and Obesity care segment provides products in the areas of insulins, GLP-1 and related delivery systems, oral antidiabeti...

More about NVO

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Forte Capital LLC , based on Form 13F filings with the SEC.

News

Stay updated on Forte Capital LLC with notifications on news.

Account

Forte Capital LLC Novo Nordisk A S Transaction History